Conference Description
The Translation Machinery in Health and Disease GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators.
Translation of mRNA into protein is an essential process common to all domains of life. Despite this universality, regulatory mechanisms controlling translation are shockingly diverse across cell and tissue types, as well as between organisms. The power of understanding and exploiting the wide array of translational control mechanisms known to date has been harnessed for the development of antibiotics, antifungals, chemotherapies, and the blockbuster mRNA vaccines. The Translation Machinery in Health and Disease GRS seeks to connect young scientists studying protein synthesis hailing from a variety of approaches and model systems to share their expertise and learn about the diverse world of translational control.
Additionally, we will have a designated mentoring panel focused on careers in academia and industry, as well as representatives from several companies with special interests in recruiting trainees with expertise in translational control and RNA Biology.
Applicants for oral presentations will be considered beyond the initial abstract deadline until December 20th 2024.
An outline of the program components for this GRS is displayed below. The seminar chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by December 24, 2024. Please check back for updates.
